FGFR3 and TP53 mutations in a prospective cohort of Belarusian bladder cancer patients
Saved in:
| Date: | 2014 |
|---|---|
| Main Authors: | M. P. Smal, A. I. Rolevich, S. L. Polyakov, S. A. Krasny, R. I. Goncharova |
| Format: | Article |
| Language: | English |
| Published: |
2014
|
| Series: | Experimental Oncology |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0000409033 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
FGFR3 and TP53 mutations in a prospective cohort of Belarusian bladder cancer patients
by: Smal, M.P., et al.
Published: (2014)
by: Smal, M.P., et al.
Published: (2014)
FGFR3 R249C (742 C>T) mutation in patients with bladder cancer
by: Ya. M. Mishchuk, et al.
Published: (2016)
by: Ya. M. Mishchuk, et al.
Published: (2016)
Association of TP53 Arg72Pro polymorphism (rs1042522) with bladder cancer risk in the Ukrainian population
by: Ya. M. Mishchuk, et al.
Published: (2018)
by: Ya. M. Mishchuk, et al.
Published: (2018)
Interplay of host genome and tumour genome in bladder cancer
by: M. P. Smal, et al.
Published: (2019)
by: M. P. Smal, et al.
Published: (2019)
BER gene polymorphisms associated with key molecular events in bladder cancer
by: Smal, M.P., et al.
Published: (2018)
by: Smal, M.P., et al.
Published: (2018)
Bladder sparing surgery in high-grade bladder cancer
by: Yakovlev, P.G., et al.
Published: (2023)
by: Yakovlev, P.G., et al.
Published: (2023)
Molecular genetic testing of FGFR3 gene mutation in the differential diagnosis of achondroplasia and hypochondroplasia
by: I. M. Dmytruk, et al.
Published: (2015)
by: I. M. Dmytruk, et al.
Published: (2015)
TP53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia
by: N. I. Bilous, et al.
Published: (2014)
by: N. I. Bilous, et al.
Published: (2014)
Association of polymorphisms in intron 2 of FGFR2 and breast cancer risk in chinese women
by: Z. Pan, et al.
Published: (2016)
by: Z. Pan, et al.
Published: (2016)
Acute L-glutamine deprivation affects the expression of TP53-related protein genes in U87 glioma cells
by: D. O. Minchenko, et al.
Published: (2014)
by: D. O. Minchenko, et al.
Published: (2014)
АСОЦІАЦІЯ МІЖ ЕКСПРЕСІЄЮ ЛІПОПРОТЕЇНЛІПАЗИ ТА ПОЛІМОРФІЗМАМИ ГЕНА TP53 У ХВОРИХ НА ХРОНІЧНУ ЛІМФОЦИТАРНУ ЛЕЙКЕМІЮ
by: Abramenko, I., et al.
Published: (2023)
by: Abramenko, I., et al.
Published: (2023)
Results of mutation status gene HER-2/NEU in patients with breast cancer in Ukraine
by: B. T. Klimuk, et al.
Published: (2017)
by: B. T. Klimuk, et al.
Published: (2017)
Microarray based gene expression profiling of advanced gall bladder cancer
by: Kumar, A., et al.
Published: (2023)
by: Kumar, A., et al.
Published: (2023)
Quinazoline inhibitors of protein kinase FGFR1
by: A. A. Hryshchenko, et al.
Published: (2010)
by: A. A. Hryshchenko, et al.
Published: (2010)
From the cohort of devotees
by: M. Barabash
Published: (2013)
by: M. Barabash
Published: (2013)
From the cohort of boychukists
by: O. M. Diduk
Published: (1993)
by: O. M. Diduk
Published: (1993)
Peculiarities of urinary bladder cancer tumor cells apoptosis response for neoadjuvant chemotherapy
by: A. I. Jatsyna, et al.
Published: (2011)
by: A. I. Jatsyna, et al.
Published: (2011)
The impact of morphine treatment on bladder cancer cell proliferation and apoptosis: in vitro studies
by: Harper, P., et al.
Published: (2018)
by: Harper, P., et al.
Published: (2018)
ERN1 knockdown modifies the hypoxic regulation of TP53, MDM2, USP7 and PERP gene expressions in U87 glioma cells
by: S. V. Danilovskyi, et al.
Published: (2014)
by: S. V. Danilovskyi, et al.
Published: (2014)
Chromatin enrichment of histone marks H4Ac and H3K9me3 in TP53 gene domain in breast cells
by: G. C. Santos, et al.
Published: (2014)
by: G. C. Santos, et al.
Published: (2014)
ВАРІАНТ ГЕНА TP53 (rs 1625895, 13494G>A) ПОВ’ЯЗАНИЙ ІЗ ЛОКАЛІЗАЦІЄЮ НОВОУТВОРЕННЯ У ХВОРИХ НА ЛЕЙОМІОМУ МАТКИ
by: Kornatska, A.G., et al.
Published: (2023)
by: Kornatska, A.G., et al.
Published: (2023)
Evolutionary karyotypic theory of cancer versus conventional cancer gene mutation theory
by: A. A. Stepanenko, et al.
Published: (2012)
by: A. A. Stepanenko, et al.
Published: (2012)
Analysis of MLH1, MSH2 and CAS 20q13 mutations in platinum refractory patients with the ovarian cancer
by: V. G. Dubinina, et al.
Published: (2014)
by: V. G. Dubinina, et al.
Published: (2014)
Spectrum of mutations in patients with organic acidurias from Ukraine
by: Barvinska, O.I., et al.
Published: (2018)
by: Barvinska, O.I., et al.
Published: (2018)
Biological features of serous ovarian cancer with regard to the r53 expression and its modulators
by: I. P. Nesina, et al.
Published: (2015)
by: I. P. Nesina, et al.
Published: (2015)
Математична модель взаємозв'язку генотипу хворих РМЗ по BRCA1 і TP53 і гістологічного типу пухлини на основі методу множинної регресії
by: Оразаєва, Айнур, et al.
Published: (2021)
by: Оразаєва, Айнур, et al.
Published: (2021)
Analysis of mutations in GBA gene in Ukrainian patients with Gaucher disease
by: N. V. Olkhovych, et al.
Published: (2017)
by: N. V. Olkhovych, et al.
Published: (2017)
Clinical implications of p53 alterations in oral cancer progression: a review from India
by: Patel, K.R., et al.
Published: (2018)
by: Patel, K.R., et al.
Published: (2018)
Association of elevated vitamin B12 with oncohematological diseases in a cohort of 79,524 patients from Latvia
by: Gavars, D., et al.
Published: (2023)
by: Gavars, D., et al.
Published: (2023)
Multiple arterial revascularization in CABG surgery – investigation of long-term benefi t in a cohort of 3129 consecutive patients
by: O. Chevtchik, et al.
Published: (2015)
by: O. Chevtchik, et al.
Published: (2015)
Ovarian cancer: family cancer syndrome and clinical significance of testing of the mutations in BRCA1 and BRCA2?genes
by: O. V. Paliichuk, et al.
Published: (2016)
by: O. V. Paliichuk, et al.
Published: (2016)
Breast cancer immunohistochemical features in young women with BRCA1/2 mutations
by: Zakhartseva, L.M., et al.
Published: (2009)
by: Zakhartseva, L.M., et al.
Published: (2009)
The JAK2 V617F mutation in lung cancer: caveat emptor
by: Langabeer, S.E.
Published: (2018)
by: Langabeer, S.E.
Published: (2018)
Mutation 6174delT in the BRCA2 gene in men with prostate cancer in Ukraine
by: Ye. V. Horodetska, et al.
Published: (2018)
by: Ye. V. Horodetska, et al.
Published: (2018)
On modular representations of semigroups Sp Ч Tp
by: V. Bondarenko, et al.
Published: (2013)
by: V. Bondarenko, et al.
Published: (2013)
ERRATUM FOR CYSTECTOMY IN METASTATIC BLADDER CANCER: FEASIBILITY, SAFETY AND OUTCOMES PUBLISHED IN EXP ONCOL 2024;46(4)
Published: (2025)
Published: (2025)
Study of SNRPN genetic and epigenetic mutations in Prader-Willi and Angelman patients
by: Chernushyn, S.Yu., et al.
Published: (2018)
by: Chernushyn, S.Yu., et al.
Published: (2018)
Association of polymorphisms in genes involved in DNA repair and cell cycle arrest with breast cancer in a vietnamese case¬control cohort
by: N. T.N. Thanh, et al.
Published: (2021)
by: N. T.N. Thanh, et al.
Published: (2021)
Lysozyme as the marker of the microbial in-toxication of the bladder
by: I. P. Pustovojt, et al.
Published: (2014)
by: I. P. Pustovojt, et al.
Published: (2014)
Lysozyme as the marker of the microbial intoxication of the bladder
by: I. P. Pustovojt, et al.
Published: (2014)
by: I. P. Pustovojt, et al.
Published: (2014)
Similar Items
-
FGFR3 and TP53 mutations in a prospective cohort of Belarusian bladder cancer patients
by: Smal, M.P., et al.
Published: (2014) -
FGFR3 R249C (742 C>T) mutation in patients with bladder cancer
by: Ya. M. Mishchuk, et al.
Published: (2016) -
Association of TP53 Arg72Pro polymorphism (rs1042522) with bladder cancer risk in the Ukrainian population
by: Ya. M. Mishchuk, et al.
Published: (2018) -
Interplay of host genome and tumour genome in bladder cancer
by: M. P. Smal, et al.
Published: (2019) -
BER gene polymorphisms associated with key molecular events in bladder cancer
by: Smal, M.P., et al.
Published: (2018)